Prescient Therapeutics (ASX:PTX) – TechKnow Invest Roadshow, August 2023

Prescient Therapeutics (ASX:PTX) – TechKnow Invest Roadshow, August 2023

[videojs_hls url=’//du7x25at22z7c.cloudfront.net/426195/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2023/Int_Prescient_360_230814.jpG’]

 

Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network


Source: Finance News Network

Share this post